Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 8, 2018 (9 years ago)

E-Z-Paste Barium Sulfate Esophageal Cream

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of one lot.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

E-Z-Paste Barium Sulfate Esophageal Cream (60% w/w), 454 g tube, Rx only, Manufactured by E-Z-EM Canada Inc. for E-Z-EM Inc. a subsidiary of Bracco Diagnostics Inc., Monroe Twp., NJ 0883, NDC 32909-770-01

Affected NDC 32909-0770-01

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
E-Z-Paste
Barium Sulfate
NDC 32909-0770
.6 g/g Cream
Oral
E-Z-EM Canada Inc Rx
Recalling firm
Bracco Diagnostics Inc.
NDC code
32909-770-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0609-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Bracco Diagnostics Inc.

All 2018 recalls
Class III · Low risk

Tagitol V Barium Sulfate Suspension

Failed Stability Specifications: Tagitol V Barium Sulfate Lot #65846 sampled at 10 months exhibited results above the upper specification for viscosity.

Terminated Stability / shelf life Bracco Diagnostics Inc NDC 32909-814-53 D-914-2013
Class II · Moderate risk

Gastrografin

Presence of foreign substance: One lot of the product may contain black foreign particles

Terminated Particulate / foreign matter Bracco Diagnostics Inc NDC 0270-0445-40 D-885-2013
Class II · Moderate risk

Cardiogen-82

GMP deviation; Sr-82 levels exceeded alert limit specification

Terminated cGMP deviation Bracco Diagnostics Inc NDC 0270-0091-01 D-1684-2012

Other stability / shelf life recalls from 2018

All stability / shelf life recalls
Class III · Low risk

Megestrol Acetate Oral Suspension

Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.

Terminated Stability / shelf life Breckenridge Pharmaceutical, Inc. D-0279-2019
Class II · Moderate risk

Nystatin and Triamcinolone Acetonide Cream

Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.

Terminated Stability / shelf life Dr. Reddy's Laboratories, Inc. NDC 43598-431-44 D-0007-2019